Aktie A2QCB4 QLY BIOTECH GROUP CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen QLY Biotech Group Corp.

Aktien

A2QCB4

US05478L1052

LQLY

Markt geschlossen - OTC Markets
Andere Börsenplätze
 20:45:33 05.09.2023 		% 5 Tage % 1. Jan.
1 USD -5,66 % Intraday Chart für QLY Biotech Group Corp. -.--% -.--%
2023 QLY Biotech Group Corp. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 28. Februar 2023 CI
2023 QLY Biotech Group Corp. meldet Ergebnis für das erste Quartal zum 30. November 2022 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
QLY BIOTECH GROUP CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QLY Biotech Group Corp. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
QLY BIOTECH GROUP CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QLY Biotech Group Corp. Reports Earnings Results for the First Quarter Ended November 30, 2022
QLY BIOTECH GROUP CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
QLY Biotech Group Corp. Reports Earnings Results for the Full Year Ended August 31, 2022
QLY Biotech Group Corp. Auditor Raises 'Going Concern' Doubt
QLY BIOTECH GROUP CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
QLY BIOTECH GROUP CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AZAR INTERNATIONAL CORP. : Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Azar International Corp. Announces CFO Changes
Azar International Corp. Announces CEO Changes
Azar International Corp. Announces Management Changes
Lixue Yang acquired a 77% stake in Azar International Corp. from Hilario Lopez Vargas for $0.35 million.
AZAR INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-Q)
Azar International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022
AZAR INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-Q)
Azar International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022
Azar International Corp. Auditor Raises 'Going Concern' Doubt
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QCB4 Aktie
  4. Nachrichten QLY Biotech Group Corp.
  5. Andere Sprachen